[Federal Register Volume 64, Number 225 (Tuesday, November 23, 1999)]
[Notices]
[Page 65714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-30522]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Blood Donor Suitability Workshop; Public Workshop

Agency: Food and Drug Administration, HHS.

Action: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a public 
workshop entitled ``Blood Donor Suitability Workshop.'' The purpose of 
the public workshop is to provide an open forum for discussion of 
specific donor suitability issues associated with donor deferrals.
    Date and Time: The public workshop will be held on December 9, 
1999, 8 a.m. to 5 p.m.
    Location: The public workshop will be held at 5630 Fishers Lane, 
rm. 1066, Rockville, MD 20857.
    Contact: Joseph Wilczek, Center for Biologics Evaluation and 
Research (HFM-350), Food and Drug Administration, 1401 Rockville Pike, 
Rockville, MD 20852-1448, 301-827-6129, FAX 301-827-2843.
    For information regarding the public workshop and registration: 
Therese Burke, Laurel Consulting Group, 1815 Fort Meyer Dr., suite 300, 
Arlington, VA 22209, 703-351-7676, FAX 703-528-0716, E-mail: 
[email protected].
    Registration: Early registration is recommended on or before 
November 26, 1999. Mail or fax registration information (including 
name, title, firm name, address, telephone, and fax number) to Therese 
Burke (address above). Registration at the site will be done on a space 
available basis on the day of the workshop, beginning at 7:30 a.m. 
There is no registration fee for the workshop. If you need special 
accommodations due to a disability, please contact Therese Burke at 
least 7 days in advance.
    Agenda: FDA is holding a public workshop to gather scientific data 
on specific donor suitability issues affecting donor deferrals and to 
evaluate how these donor deferrals may affect the nation's blood 
supply. The three key topics to be discussed at the workshop include: 
(1) Donor deferral registries, including deferral registries that are 
used in-house, at mobile collection sites, as well as registries shared 
by several facilities; (2) minimum donor weight and adjustment of blood 
volume based on body weight; and (3) deferral of donors who have a 
history of cancer.
    Transcripts: Transcripts of the public workshop may be requested in 
writing from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
approximately 15 working days after the public workshop at a cost of 10 
cents per page. The public workshop transcript will also be available 
on the Center for Biologics Evaluation and Research website at http://
www.fda.gov/cber/minutes/workshop-min.htm.

    Dated: November 17, 1999.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 99-30522 Filed 11-22-99; 8:45 am]
BILLING CODE 4160-01-F